Should we still consider colchicine in treating patients with COVID-19?

被引:0
|
作者
Putra, O. N. [1 ]
Sofia, S. [1 ]
Widad, A. [1 ]
Oktaviani, C. R. [1 ]
机构
[1] Hang Tuah Univ, Dept Clin Pharm, Study Program Pharm, Surabaya, East Java, Indonesia
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1073 / 1074
页数:2
相关论文
共 50 条
  • [41] COVID-19 and Diabetes: What Should We Expect?
    Pedrosa, Marlus da Silva
    Neves Nogueira, Fernando
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2020, 14 (06): : 1133 - 1134
  • [42] Dupilumab and COVID-19: What should we expect?
    Patruno, Cataldo
    Stingeni, Luca
    Fabbrocini, Gabriella
    Hansel, Katharina
    Napolitano, Maddalena
    DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [43] Should we discount the laboratory origin of COVID-19?
    Segreto, Rossana
    Deigin, Yuri
    McCairn, Kevin
    Sousa, Alejandro
    Sirotkin, Dan
    Sirotkin, Karl
    Couey, Jonathan J.
    Jones, Adrian
    Zhang, Daoyu
    ENVIRONMENTAL CHEMISTRY LETTERS, 2021, 19 (04) : 2743 - 2757
  • [44] Convalescent COVID-19 Patients on Hemodialysis: When Should We End Isolation?
    Murt, Ahmet
    Altiparmak, Mehmet Riza
    NEPHRON, 2020, 144 (07) : 343 - 344
  • [45] Should we discount the laboratory origin of COVID-19?
    Rossana Segreto
    Yuri Deigin
    Kevin McCairn
    Alejandro Sousa
    Dan Sirotkin
    Karl Sirotkin
    Jonathan J. Couey
    Adrian Jones
    Daoyu Zhang
    Environmental Chemistry Letters, 2021, 19 : 2743 - 2757
  • [46] What Should We Be Studying Regarding COVID-19?
    Smith, David A.
    Nazir, Arif
    Katz, Paul R.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2020, 21 (08) : 1010 - 1011
  • [47] Should we still consider blood pressure measurements in the clinic?
    Boivin, Jean-Marc
    Fay, Renaud
    JOURNAL OF HYPERTENSION, 2014, 32 (11) : 2144 - 2145
  • [48] SHOULD WE CONSIDER FRAILTY WHEN TREATING ATRIAL FIBRILLATION?
    Wilkinson, C.
    Todd, O.
    Clegg, A.
    Gale, C. P.
    Hall, M.
    AGE AND AGEING, 2019, 48
  • [49] Colchicine for the treatment of COVID-19
    Mikolajewska, Agata
    Fischer, Anna-Lena
    Piechotta, Vanessa
    Mueller, Anika
    Metzendorf, Maria-Inti
    Becker, Marie
    Dorando, Elena
    Pacheco, Rafael L.
    Martimbianco, Ana Luiza C.
    Riera, Rachel
    Skoetz, Nicole
    Stegemann, Miriam
    EMERGENCIAS, 2023, 35 (04): : 300 - 301
  • [50] Should we still consider Dravet syndrome an epileptic encephalopathy?
    Auvin, Stephane
    EPILEPSY & BEHAVIOR, 2014, 36 : 80 - 81